WOODHOUSE DAVID J 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Jan 18, 2024
Insider Transaction Report
Form 4
WOODHOUSE DAVID J
DirectorCEO and acting CFO
Transactions
- Tax Payment
Common Stock
2024-01-16$1.34/sh−13,032$17,463→ 131,822 total
Holdings
- 80,000(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
- [F2]Shares held by The Woodhouse Family Trust 9/8/05.